108 related articles for article (PubMed ID: 3484635)
21. Factor VII congenital deficiency. Clinical picture and classification of the variants.
Mariani G; Mazzucconi MG
Haemostasis; 1983; 13(3):169-77. PubMed ID: 6350122
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII.
Broze GJ; Hickman S; Miletich JP
J Clin Invest; 1985 Sep; 76(3):937-46. PubMed ID: 2995451
[TBL] [Abstract][Full Text] [Related]
23. Rare factor VII variant inherited through genetic variant in proband's mother and another genetic variant in proband's father.
Svendsen J; Osterud B
Pediatr Hematol Oncol; 1987; 4(2):145-51. PubMed ID: 3152920
[TBL] [Abstract][Full Text] [Related]
24. Characterization and comparison of immune-depleted and hereditary factor-VII-deficient plasmas as substrate plasmas for factor VII assays.
Brandt JT; Triplett DA; Fair DS
Am J Clin Pathol; 1986 May; 85(5):583-9. PubMed ID: 3518398
[TBL] [Abstract][Full Text] [Related]
25. Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.
Levanon M; Rimon S; Shani M; Ramot B; Goldberg E
Br J Haematol; 1972 Dec; 23(6):669-77. PubMed ID: 4675008
[No Abstract] [Full Text] [Related]
26. [ELISA method for the determination of factor VII antigen].
Jorquera JI; Aznar JA; Monteagudo J; Montoro JM; Casaña P; Pascual I; Bañuls E; Curats R; Llopis F
Sangre (Barc); 1989 Dec; 34(6):514-7. PubMed ID: 2629128
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the nature of mildly prolonged prothrombin times.
Mazzucconi MG; Mariani G; Chistolini A; Lasagni RP; Motta M; Ghirardini A; Altieri D; Mannucci PM; Mandelli F
Am J Hematol; 1987 Jan; 24(1):37-45. PubMed ID: 3799594
[TBL] [Abstract][Full Text] [Related]
28. Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.
Pfeiffer C; Mathieu-Dupas E; Logghe P; Lissalde-Lavigne G; Balicchi J; Caliskan U; Valentin T; Laune D; Molina F; Schved JF; Giansily-Blaizot M
Thromb Res; 2016 May; 141():22-7. PubMed ID: 26962982
[TBL] [Abstract][Full Text] [Related]
29. Hemophilia B with associated factor VII deficiency: a distinct variant of hemophilia B with low factor VII activity and normal factor VII antigen.
Girolami A; Dal Bo Zanon R; De Marco L; Cappellato G
Blut; 1980 Apr; 40(4):267-73. PubMed ID: 7370439
[TBL] [Abstract][Full Text] [Related]
30. Factor VII Padua defect: the heterozygote population.
Girolami A; Dal Bo Zanon R; Zanella F; Procidano M; Ruffato G
Acta Haematol; 1982; 68(1):34-8. PubMed ID: 6812354
[TBL] [Abstract][Full Text] [Related]
31. In vivo studies of the role of factor VII in hemostasis.
Giles AR; Tinlin S; Brosseau L; Hoogendoorn H
Blood; 1985 May; 65(5):1197-200. PubMed ID: 3995170
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay.
Tirindelli MC; Mariani G; Mazzucconi MG; Iacopino G; Carbonaro M; Ghirardini A; Motta M; Mandelli F
Am J Hematol; 1987 Dec; 26(4):313-21. PubMed ID: 2961255
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis and secretion of factor VII, protein C, protein S, and the Protein C inhibitor from a human hepatoma cell line.
Fair DS; Marlar RA
Blood; 1986 Jan; 67(1):64-70. PubMed ID: 3000483
[TBL] [Abstract][Full Text] [Related]
34. Congenital factor VII deficiency. Clinical and laboratory characteristics of a newly discovered kindred.
Kernoff LM; Hughes J; Denson KW
Clin Lab Haematol; 1982; 4(2):109-15. PubMed ID: 7116793
[TBL] [Abstract][Full Text] [Related]
35. Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to alpha VIIa and higher flux within the coagulation pathway.
Mitropoulos KA; Esnouf MP; Meade TW
Atherosclerosis; 1987 Jan; 63(1):43-52. PubMed ID: 3493783
[TBL] [Abstract][Full Text] [Related]
36. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
37. Suppression of plasma-activated factor VII levels by warfarin therapy.
Sakata T; Kario K; Matsuo T; Katayama Y; Matsuyama T; Kato H; Miyata T
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):241-6. PubMed ID: 7749832
[TBL] [Abstract][Full Text] [Related]
38. Very low activated factor VII and reduced factor VII antigen in familial abetalipoproteinaemia.
Miller GJ; Mitropoulos KA; Nanjee MN; Howarth DJ; Martin JC; Esnouf MP; Reeves BE; Miller NE; Cooper JA
Thromb Haemost; 1998 Aug; 80(2):233-8. PubMed ID: 9716144
[TBL] [Abstract][Full Text] [Related]
39. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
Morrissey JH
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
[TBL] [Abstract][Full Text] [Related]
40. Activity and antigen of coagulation factors VII and X in five patients with abnormal chromosome 13.
Fukushima Y; Kuroki Y; Iizuka A
Jinrui Idengaku Zasshi; 1987 Jun; 32(2):91-6. PubMed ID: 3437574
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
